Quest Diagnostics began performing COVID-19 antibody testing
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…
On Apr. 21, 2020, Bayer Mississauga, Ontario announced a partnership with the Population Health Research Institute (PHRI) to…
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
On Apr. 21, 2020, a panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISᆴ (ravulizumab-cwvz)…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….